Conference Overview

For More Information

The VIII International Aromatase Conference will review the most recent data from the latest research on aromatase, the key enzyme involved in estrogen biosynthesis. The conference is the major forum for international experts to discuss the impact of their results and provide perspectives for the future. This research has important implications for normal tissue physiology/development and the etiology/treatment of hormone-related diseases, most notably breast cancer.The conference is structured to provide for lively debate and the opportunity for participants to present data in poster sessions.

Aromatase 2006 will be of interest to scientists and clinicians involved in basic biology, translational research, and clinical practice relating to estrogen regulated processes and diseases, particularly breast cancer.

A social program includes a reception at The National Aquarium in Baltimore and a symposium dinner and tour at Mount Vernon in Washington, D.C.

Scientific Topics	Organizing Committee
Regulation of aromatase expression Consequences of aromatase excess/deficiency Aromatase in model systems Aromatase in endocrine and peripheral tissues Aromatase inhibitors: endocrinological, biological, molecular, and clinical effects Treatment of early and advanced breast cancer Inhibitors and prevention of breast cancer Tumor response and resistance to aromatase inhibitors Long-term effects of estrogen deprivation	Angela Brodie, Chair (USA) Shuian Chen (USA) Mitch Dowsett (UK) Paul Goss (Canada) James Ingle (USA) Per Lønning (Norway) William Miller (UK) Richard Santen (USA) Hironobu Sasano (Japan) Evan Simpson (Australia) Raj Tekmal (USA)

Scientific Topics

Organizing Committee

Regulation of aromatase expression
Consequences of aromatase excess/deficiency
Aromatase in model systems
Aromatase in endocrine and peripheral tissues
Aromatase inhibitors: endocrinological, biological, molecular, and clinical effects
Treatment of early and advanced breast cancer
Inhibitors and prevention of breast cancer
Tumor response and resistance to aromatase inhibitors
Long-term effects of estrogen deprivation

Angela Brodie, Chair (USA)
Shuian Chen (USA)
Mitch Dowsett (UK)
Paul Goss (Canada)
James Ingle (USA)
Per Lønning (Norway)
William Miller (UK)
Richard Santen (USA)
Hironobu Sasano (Japan)
Evan Simpson (Australia)
Raj Tekmal (USA)

Deadline for Abstract Submissions and Poster Presentations: July 1, 2006

Primary Sponsors: AstraZeneca, Novartis, Pfizer

This page was last updated on: September 5, 2006.